Stocktoria
MANGOCEUTICALS, INC. MGRX
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2023-03-21
MANGOCEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 54.9% | 61.7% | 59.0% | 54.3% |
| Operating margin | -3954.3% | -1294.4% | -1260.3% | -22279.7% |
| Net margin | -4526.8% | -1413.6% | -1259.4% | -22352.1% |
| FCF margin | — | — | -957.1% | -15545.6% |
| Return on assets | -128.3% | -56.6% | -876.7% | -199.2% |
| Return on equity | -135.8% | -62.4% | -1189.1% | -325.4% |
| Current ratio | 1.74 | 0.05 | 3.96 | 2.67 |
| Revenue growth | -26.0% | -15.8% | 8083.2% | — |
Source: SEC EDGAR filings · CIK 0001938046 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.